Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function  by Hassanein, Waleed H. et al.
practice of donor heart preservation during the past 20
years.1-3 Current preservation protocols use hypothermic
arrest and simple storage, using a variety of crystalloid-
based cardioplegic and preservation solutions. These tech-
niques limit organ procurement and safe storage time to 4
to 6 hours. In addition, they invariably subject donor hearts
to periods of ischemia and thus may result in time-depen-
dent ischemia-reperfusion injuries. The use of blood per-
fusates has been suggested as a more suitable method for
clinical donor heart preservation.4-8 We hypothesized that
continuous, sanguineous perfusion of the donor heart in
the beating, working state would result in a homogeneous
distribution of substrate and might prevent time-dependent
ischemia-reperfusion injury, thus prolonging the preserva-
tion period. This study uses an isolated swine heart model
to compare continuous sanguineous perfusion of the donor
heart in the beating, working state to standard hypothermic
storage in the arrested state. 
D espite numerous investigations aimed at improving thequality of donor hearts and prolonging the preserva-
tion time, few changes have been made in the clinical
Objectives: Improving methods of donor heart preservation may permit
prolonged storage and remote procurement of cardiac allografts. We
hypothesized that continuous, sanguineous perfusion of the donor heart
in the beating, working state may prolong myocardial preservation.
Methods: We developed a portable perfusion apparatus for use in donor
heart preservation. Contractile, metabolic, and vasomotor functions
were monitored simultaneously in an isolated swine heart. The metabol-
ic state was monitored by myocardial tissue pH. Vasomotor function was
assessed in isolated coronary ring chambers. Hearts were randomized
into 3 groups: group I (n = 5), cardioplegic arrest, 12-hour storage at
4°C with modified Belzer solution, and 2-hour sanguineous reperfusion
in the working state; group II (n = 6), 12-hour continuous perfusion in
the beating working state, 30 minutes of arrest (to simulate re-implan-
tation time), and 2 hours of reperfusion, as above; group III (n = 7),
coronary ring control hearts. Results: At 2 hours of reperfusion, left ven-
tricular developed pressure in group II was higher than in group I
(mean ± standard deviation: 90 ± 6 mm Hg, 53 ± 15 mm Hg, P = .005).
Significantly less myocardial edema was observed in group II than in
group I (73% ± 4%, 80% ± 1% water content, P = .01). Significantly less
myocardial acidosis was noted in group II than in group I during preser-
vation (pH 7.3 ± 0.01, 6.1 ± 0.03, P < .001) and reperfusion (pH 7.3 ±
0.008, 6.8 ± 0.05, P < .001). Coronary endothelial vasomotor function
was better preserved in group II than in group I as evidenced by dose-
response relaxation of coronary rings to 10–8 mol/L bradykinin (37%,
55% D baseline, P = .01). Conclusion: This new method extends the cur-
rent preservation limit and avoids time-dependent ischemic injury,
thereby allowing for distant procurement of donor organs. (J Thorac
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Methods
The protocol was approved by our institutional animal care
committee in accordance with the 1996 “Guide for the Care
and Use of Laboratory Animals” prepared by the Institute of
Laboratory Animal Resources of the National Research
Council and published by the National Academy Press.
Animal preparation. Twenty-nine male Yorkshire pigs
(90-100 kg) were premedicated with intramuscular ketamine
(20 mg/kg) and intramuscular xylazine (2 mg/kg), intubated,
and their lungs mechanically ventilated with 100% oxygen.
Anesthesia was maintained with 1% to 2% isoflurane. The
right femoral artery and vein were isolated and cannulated for
hemodynamic monitoring and support. A median sternotomy
was performed and the pericardium was opened. After isola-
tion of the great vessels, heparin was infused at a rate of 200
U/kg to achieve an activated clotting time of 400 seconds or
more. A Khuri tissue pH electrode (Vascular Technology, Inc,
Lowell, Mass) was inserted into the anterior ventricular wall
for on-line measurement of myocardial pH. Hearts were ran-
domized into 1 of the 3 groups (Fig 1).
Experimental groups.
Group I: Arrest with and simple immersion in 4°C
University of Wisconsin solution (UW solution, n = 5). After
the instruments were inserted as described herein, the aorta
was crossclamped. Hearts were arrested by antegrade infu-
sion of 1000 mL of UW solution (prepared according to
DuPont guidelines [EI du Pont de Nemours and Company,
Wilmington, Del] by adding 40 U of regular insulin, 16 mg of
dexamethasone, and 200,000 U of penicillin G) into the aor-
tic root at a perfusion pressure of 50 to 60 mm Hg and a tem-
perature of 4°C. Cardioplegic solution was vented through
venotomies in the inferior vena cava and the left superior pul-
monary vein. Hearts were excised and immediately immersed
in a plastic bag filled with 1500 mL of UW solution. A sec-
ond Khuri tissue pH electrode was placed in the posterior
wall of the left ventricle. The heart was stored on ice for 12
hours. At the end of the preservation period, hearts were
flushed with 500 mL of normal saline solution at room tem-
perature and then sanguineously reperfused for 2 hours, as
described in the Reperfusion protocol section.
Group II: Normothermic blood-perfused hearts in the beat-
ing, working state (blood group, n = 6). After instrumenta-
tion as described herein, the right atrium and the inferior vena
cava were cannulated with a 28F/36F 2-staged venous can-
nula (DLP, Inc, Grand Rapids, Mich), which was clamped
and connected to the perfusion circuit (Fig 2). At the time of
aortic crossclamping, the 2-staged cannula was unclamped to
exsanguinate the animal into the perfusion circuit. Blood in
the perfusion circuit was oxygenated with 95% oxygen/5%
carbon dioxide at a rate of 2 L/min and warmed to 37°C with
a hollow-fiber membrane oxygenator (Minimax, Medtronic
Inc, Anaheim, Calif). A leukocyte-depleting filter (Pall Filters
Biomedical Products Corp, East Hills, NY) was used in the
perfusion circuit during the preservation protocol. Hearts
were immediately dissected and perfused through the aortic
root (nonworking model) with a 28F arterial cannula that was
connected to one arterial end of the perfusion circuit. The
pulmonary artery was cannulated with a 28F arterial cannula
and connected to the venous reservoir of the perfusion circuit
for collection of the coronary effluent. Coronary flow and
aortic flow were measured by placing 6N flow probes
(Transonic Systems, Ithaca, NY) on the pulmonary artery and
the aortic cannula, respectively. The pulmonary veins and the
superior and inferior venae cavae were tied off. A Mikro-Tip
pressure transducer (Millar Instruments, Inc, Houston, Tex)
was placed into the left ventricle through the left superior
pulmonary vein to measure intracavitary pressures. A second
Khuri tissue pH electrode was placed in the posterior left
ventricular wall. A 22F arterial cannula, connected to the sec-
ond arterial line of the perfusion circuit, was placed into the
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Fig 1. Timeline of the study protocol. The 30-minute period (A) in group I (UW) represents the period for grad-
ual rewarming and instrumentation of the heart in preparation for reperfusion. The 30-minute period (B) in group
II (blood) represents blood cardioplegic arrest. R, Two-hour reperfusion period.
left atrium via the right superior pulmonary vein and secured
with a purse-string suture. This cannula was used as the per-
fusion line in the working heart model. The inflow to the
aorta was gradually reduced and blood flow to the left atrium
was increased to change the heart to a working state for the
12-hour preservation period. During this period the pump
flow and afterload column height were adjusted to achieve
coronary blood flow of 1 to 2 mL/g wet heart weight per
minute. At 6 hours of preservation, 1500 to 2000 mL of the
circulating blood was drained off the perfusion circuit and
replaced by a similar volume of fresh homologous blood. At
the end of the preservation period, the hearts were arrested
with standard 4:1 blood/cardioplegic solution (in a 500 mL
mixture of 2.5% dextrose, 0.25% NaCl, 25 mmol/L KCl, and
50 mmol/L NaHCO3 added to the heparinized blood just
before use) at a perfusion pressure of 50 to 60 mm Hg and a
temperature of 20°C to 22°C for 30 minutes to simulate reim-
plantation time. At the end of 30 minutes of arrest, all hearts
were sanguineously reperfused with fresh homologous blood
from another swine (see Reperfusion protocol).
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Fig 2. Schema of perfusion apparatus. Panel A shows the monitoring equipment and chamber for the heart. Panel
B is a detailed enlargement of the heart chamber depicting the instrumentation. LA, Left atrium; RA, right atri-
um; PA, pulmonary artery.
Group III: Control hearts (control, n = 7). Animals were
anesthetized and ventilated as previously described. Median
sternotomy was performed and the hearts were excised and
immediately placed in standard Krebs-Henseleit solution at
4°C. This group served as controls for the coronary ring and
edema studies.
Reperfusion protocol. For each preserved heart, a second
animal was premedicated and instrumented and then exsan-
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Fig 3. Mean developed pressure for group II (blood, n = 6) hearts during the 12-hour preservation period. Data
are expressed as mean ± standard error of the mean.
Fig 4. Myocardial tissue pH (normalized for 37°C) for group I (UW, n = 5) and group II (blood, n = 6) in the
anterior and posterior walls of the left ventricle. Panel A depicts the 12-hour preservation period. Group I hearts
were arrested and stored in UW solution, whereas group II hearts were continuously perfused with blood in the
beating, working state. Significant acidosis was encountered in both left ventricular walls of group I when com-
pared with group II (6.1 ± 0.03 vs 7.3 ± 0.01 pH units, respectively, P < .001). Panel B represents the period of
rewarming and instrumentation of the heart in preparation for reperfusion in the working state in group I and car-
dioplegic arrest in group II using a standard 4:1 blood/cardioplegia ratio. Panel C depicts the 2-hour reperfusion
period. Despite reperfusion, group I remained significantly more acidotic than group II (6.1 ± 0.03 vs 7.3 ± 0.01
pH units, respectively, P < .001). Data are expressed as mean ± standard error of the mean.
guinated into the perfusion apparatus. Blood in the perfusion
circuit was oxygenated with 95% oxygen/5% carbon dioxide,
2 L/min, and warmed to 37°C with a hollow-fiber membrane
oxygenator (Monolyth, Sorin Biomedical, Irvine, Calif). A
leukocyte-depleting filter was not used during reperfusion in
either experimental group. On completion of the preservation
period, hearts in both groups were instrumented as described
in group II and reperfused for 2 hours in the working state.
Hearts were allowed to fibrillate for 1 to 2 minutes; if sinus
rhythm was not achieved, direct-current shock at increments
of 5 joules was used to defibrillate the heart. The afterload
column was stabilized at 100 cm above the coronary ostia.
Pump flow was adjusted to achieve an end-diastolic pressure
of 5 mm Hg.
Measurement of myocardial function. In addition to con-
tinuous measurement of intracavitary pressures, Starling
curves were generated at 1 and 2 hours of reperfusion by
increasing the pump flow to raise the left ventricular end-
diastolic pressure by 5 mm Hg increments while maintaining
standard afterload and measuring cardiac output. Cardiac
output was plotted against end-diastolic pressure. The ability
of the preserved hearts to return to sinus rhythm, with or
without direct-current shock or pacing, was also recorded.
Studies of isolated coronary rings. At the end of the
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Table I. Arterial blood gases, electrolytes, and other blood components
Preservation Reperfusion
Group II: Blood Group I: UW Group II: Blood 
Baseline (n = 6) (n = 5) (n = 6)
WBC count (· 103/mm3) 20 ± 7 4 ± 2 13 ± 3 12 ± 9
Hemoglobin (g/dL) 10 ± 1 8 ± 25 9 ± 2 10 ± 2
Hematocrit (%) 33 ± 3 26 ± 4 28 ± 4 29 ± 6
pH (units) 7.41 ± 0.04 7.43 ± 0.06 7.42 ± 0.04 7.36 ± 0.08
PCO2 (mm Hg) 36 ± 2 37 ± 2 39 ± 2 38 ± 2
PO2 (mm Hg) 115 ± 5 624 ± 29 677 ± 41 649 ± 64
O2 saturation (%) 99 ± 0.1 100 100 100
Sodium (mmol/L) 142 ± 2 145 ± 4 148 ± 4 146 ± 4
Potassium (mmol/L) 4 ± 1 5 ± 1 6 ± 1 6 ± 1
Calcium (mmol/L) 10.0 ± 0.3 9.2 ± 0.1 9.1 ± 0.4 9.2 ± 3.0
Bicarbonate (mmol/L) 31 ± 2.7 23 ± 0.9 25 ± 2.2 24 ± 5.5
BUN (mg/dL) 10 ± 3 7 ± 2 7 ± 1 11 ± 2
Creatinine (mg/dL) 1.5 ± 0.1 1.4 ± 0.3 1.5 ± 0.2 1.5 ± 0.1
Glucose (mg/dL) 117 ± 23 99 ± 24 110 ± 21 115 ± 54
WBC, White blood cell; Pco2, carbon dioxide tension; Po2, oxygen tension; BUN, blood urea nitrogen.
Fig 5. Mean developed pressure for group I (UW) and group II (blood) during the 2 hours of reperfusion. A sig-
nificant difference was noted between groups I and II over the second hour of reperfusion (53.3 ± 16 mm Hg vs
90 ± 6 mm Hg, respectively, P = .005). Data are expressed as mean ± standard error of the mean.
experimental protocol in each group, the left anterior
descending coronary artery was dissected and placed in 37°C
standard Krebs-Henseleit solution. The vessels were cleaned
of connective tissue, cut into four 3 · 2 mm rings, mounted
on fine wire tensiometers, and placed in individual organ
chambers filled with 10 mL standard Krebs-Henseleit solu-
tion gassed with 95% oxygen and 5% carbon dioxide. The
rings were allowed to equilibrate at a passive tension of 4 to
6 g for 60 minutes. The tensiometers were re-zeroed and the
rings were then contracted with 50 to 100 nmol of U46619 (a
prostaglandin F2a analog; Sigma Chemical Co, St Louis, Mo)
and allowed to stabilize. Once a stable contraction was
obtained, coronary vasomotor function was assessed by gen-
erating dose-response curves to cumulative concentrations of
bradykinin, 10–9 to 10–6 mol/L (endothelium-dependent coro-
nary vasodilator; Sigma), and of sodium nitroprusside
(Nipride; endothelium-independent coronary vasodilator;
Sigma), 10–7 to 10–4 mol/L.
Measurement of myocardial water content. At the end of
the reperfusion period and immediately after dissection of the
coronary vessels, the hearts from all experimental groups
were weighed to obtain their wet weight. Each specimen was
then dried in an 80°C oven for 48 hours to obtain its dry
weight. Myocardial water content (MWC) was calculated as
follows9:
MWC =([Wet weight – Dry weight]/[Wet weight]) · 100
Myocardial water content from the 2 experimental groups
was compared with that of control hearts in group III.
Assessment of myocardial metabolism. Myocardial tis-
sue pH was continuously measured by means of a micro-pH
electrode/thermistor implanted into the myocardium and con-
nected to the Khuri tissue pH monitor that measured and
stored pH and temperature data simultaneously. This method
has been previously reported.10-12 In addition, arterial blood
gases were measured hourly during preservation in group II
and during reperfusion in both groups.
Measurement of blood components. Blood electrolytes
and complete blood count were measured at 4-hour intervals
during preservation in group II and hourly during reperfusion
in both groups.
Data acquisition and analysis. All function data were
continuously recorded and digitally stored with the use of
Maclab recording equipment (AD Instruments, Milford,
Mass) and also simultaneously displayed on a Power
Macintosh computer (Apple Computers, Cupertino, Calif).
Statistical analysis was performed with the StatMost statisti-
cal package (DataMost Corp, Salt Lake City, Utah).
Categorical data were analyzed by the c 2 or 2-tailed Student’s
t test where appropriate. Continuous data were analyzed by
analysis of variance and were expressed in the text as the
mean ± standard deviation and mean ± standard error for the
figures. Data generated by the Starling curves were analyzed
by calculating the slope of each curve, and the Mann-
Whitney test was used to compare the slopes of experimental
groups I and II. Data on coronary vascular rings were ana-
lyzed by calculating the ring relaxation in response to each
concentration of the agonists as a percent change of the max-
imum contraction induced by U46619. One-half maximum
effective concentration values (EC50) were determined from
concentration-response curves of the control rings and were
used to compare the experimental groups.
Results
During preservation
Contractile function. The integrated mean of the left
ventricular developed pressure throughout the 12-hour
preservation period in group II was 77.4 ± 29 mm Hg
(Fig 3), with a coronary perfusion pressure of 52 ± 6
mm Hg. Normal sinus rhythm was achieved without
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Fig 6. Starling curves generated at 1 hour (top) and 2 hours
(bottom) of reperfusion for group I (UW) and group II
(blood). The curves were generated by increasing the pump
flow to raise the left ventricular end-diastolic pressure by 5
mm Hg increments while maintaining standard 100 cm H2O
afterload. Cardiac output was plotted against left ventricular
end-diastolic pressure. Significance was noted between the
slopes of the curves at 2 hours of reperfusion.
electrical pacing, heart rate during this period averaged
115 ± 5 beats/min, and average coronary flow was 506
± 83 mL/min.
Metabolic function. Marked myocardial tissue acido-
sis was noticed in group I compared with group II, in
which normal physiologic myocardial tissue pH was
observed (Fig 4). Mean myocardial tissue pH values
during the 12-hour preservation period were 6.1 ± 0.03
versus 7.3 ± 0.01 pH units for groups I and II, respec-
tively (P < .001). Blood gas measurements were main-
tained within normal limits during preservation in group
II and during reperfusion in both groups (Table I).
Blood characteristics. Blood components were ade-
quately maintained throughout the 12-hour preserva-
tion period (Table I). The use of a leukocyte-depleting
filter significantly reduced the white blood cell count
in group II (3.5 ± 1.9 · 103/mm3) versus baseline (20 ±
6 · 103/mm3, P < .0001).
After reperfusion. On reperfusion, all hearts in group
I required direct-current shock to convert to sinus
rhythm, whereas all hearts in group II returned to normal
sinus rhythm without pacing or direct-current shock.
Contractile function. Throughout the first hour of
reperfusion we observed no significant differences in
the integrated mean left ventricular developed pressure
between groups I (82.5 ± 9.4 mm Hg) and II (82.3 ±
3.3 mm Hg, P = .8; Fig 5). However, a marked deteri-
oration of the mean left ventricular developed pressure
was observed over the second hour of reperfusion in
group I compared with group II (53.3 ± 16 mm Hg and
90 ± 6 mm Hg, respectively, P = .005). This observa-
tion was substantiated by the Starling curves obtained
at 1 hour of reperfusion, which were comparable in the
2 groups (Fig 6). However, marked deterioration in left
ventricular function was noted in group I as evidenced
by the 2-hour Starling curves shown in Fig 6, indicat-
ing elevated left ventricular end-diastolic pressure and
low cardiac output.
Myocardial water content. A greater degree of edema
was observed in group I than in groups II and III (80%
± 1%, 73% ± 4%, 71%± 2% water content, respectively,
P = .01). There was no statistically significant differ-
ence between group II and group III (73% ± 4% vs
71% ± 2% water content, respectively, P = .14).
Metabolic function. During the preservation period
the myocardial pH fell progressively in group I (Fig 4,
A) and reached levels of severe acidosis. This acidosis
was not fully corrected during reperfusion (Fig 4, C).
Mean myocardial tissue pH levels over the 2 hours of
reperfusion were 6.1 ± 0.03 vs 7.3 ± 0.01 pH units in
group I and group II, respectively, P < .001. The blood
gas results did not differ significantly during reperfu-
sion in the 2 groups (Table I).
Blood characteristics. Blood components were ade-
quately maintained during the 2-hour reperfusion peri-
od, and the differences between the groups did not dif-
fer significantly (Table I).
Coronary vasomotor function. The EC50 was found
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Fig 7. Results from coronary vascular ring studies. Percent residual constriction at EC50 in response to
bradykinin and nitroprusside in group I (UW), group II (blood), and group III (control). Significance was noted
between groups I and II at a bradykinin concentration of 10–8 mol/L when compared with controls. No statis-
tical significance was noted between the groups in response to the administration of nitroprusside.
to be 10–8 mol/L for bradykinin and 10–6 mol/L for
nitroprusside in the control group (group III).
Endothelial dysfunction was noted in group I compared
with group II, as evidenced by the response to a 10–8
mol/L dose of bradykinin (56% ± 8% vs 37% ± 14%
residual constriction, respectively, P = .01) (Fig 7, A).
No statistically significant differences were noted in
the dose responses to a 10–6 mol/L dose of nitroprus-
side (34.6% ± 6% vs 45% ± 5% residual constriction in
groups I and II, respectively, P = .46) (Fig 7, B).
Discussion
This work demonstrated that maintenance of the
donor heart in the beating working state for 12 hours
resulted in complete preservation of contractile, meta-
bolic, and vasomotor function as compared with cur-
rent clinical protocols that use arrest and storage in UW
solution over the same period of time. Severe myocar-
dial tissue acidosis was encountered during the preser-
vation period in the UW group that was not complete-
ly reversed during reperfusion. Two hours after
reperfusion, contractile function in the hearts preserved
with UW solution was significantly worse than that in
the blood-perfused group. Coronary endothelial func-
tion, assessed by the vasodilatory response of precon-
stricted vascular rings, was markedly compromised in
the UW group compared with the blood-perfused
group. Myocardial edema was significantly increased
in the UW group but was negligible in the blood-per-
fused group.
This study confirms previous investigations that
demonstrated that preservation of the donor heart in the
hypothermic arrested state, employing a variety of crys-
talloid cardioplegic and preservation solutions, does not
prevent the onset of time-dependent ischemia-reperfu-
sion injury. Studies in human beings have also demon-
strated endothelial dysfunction after donor heart preser-
vation when current hypothermic preservation protocols
are used.13,14 This lack of protection of the endothelium
has been implicated as a possible cause of cardiac allo-
graft vasculopathy.15 Several investigators have
attempted to improve myocardial protection through the
use of hypothermic oxygenated perfusion circuits and a
variety of crystalloid cardioplegic solutions.2,3,16 These
systems have not been applied clinically. Rao, Feindel,
and Weisel17 reported that continuous perfusion of the
donor heart with blood cardioplegic solution for 4 hours
improved recovery of function as compared with simple
storage in UW solution. Despite the improved myocar-
dial function reported in this study, the 4-hour preserva-
tion period was not extended. Additionally, coronary
endothelial function and myocardial edema were not
assessed in these studies.
We used both a blood perfusate and the beating work-
ing state, albeit at a reduced workload. Blood perfusate
provides better substrate, improves oxygen delivery and
oncotic pressure, and contains endogenous free radical
scavengers and potent buffers.4-8 In our study, the beat-
ing state was crucial in ensuring a homogeneous distri-
bution of substrate, which was evidenced by the com-
parable normal rates of tissue H+ washout in both the
anterior and posterior walls of the left ventricle.
Chien and associates18,19 developed an autoperfusion
setup in which a swine heart was continuously perfused
with blood preserved in the beating working state for
up to 24 hours. Although this work demonstrated the
feasibility of safely extending the preservation period
of the donor heart, this system was too cumbersome
and impractical for widespread clinical use because it
required the preservation of the lungs, liver, pancreas,
and kidneys en bloc with the heart. As an alternative to
the method proposed by Chien and colleagues, we used
an extracorporeal circuit to sustain the heart in the beat-
ing state despite the potential adverse effects from
interactions between blood and the synthetic surface of
the extracorporeal circuit20,21 and the pump-induced
hemolysis. Our pilot studies demonstrated a rise in
plasma hemoglobin at 6 hours to 29 ± 4 mg/dL from
baseline values of 5 ± 2 mg/dL. To minimize these
adverse effects we used a leukocyte-depleting filter
during the preservation period in group II. In addition,
blood exchange transfusions were used to provide sub-
strate, to ensure an adequate supply of normal red
blood cells, to improve oxygen delivery to the heart,
and to reduce hemolysis.
Clinical implications. Compared with the current
method of hypothermic arrest and storage, our tech-
nique demonstrates the ability to safely prolong the
preservation period of donor hearts beyond the current
4- to 6-hour limit. The development of a clinical,
portable perfusion device for donor organ preservation
and transport may increase the pool of available donors
by allowing for distant procurement of organs.
Prolonged safe preservation not only will allow for bet-
ter histocompatibility cross-matching, thus reducing
the risk of early graft rejection,22 but also will create
the flexibility to perform the transplant procedure as an
elective case. In addition to better recovery of myocar-
dial and coronary vasomotor function after prolonged
preservation of the donor heart, this new technique may
reduce the incidence of cardiac allograft vasculopathy,
the leading cause of late cardiac allograft failure.15
An optimal organ preservation technique should
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meet the following conditions: (1) prevention of is-
chemia-reperfusion injury, (2) minimization of cell
swelling and edema, (3) prevention of intracellular
acidosis, and (4) provision of substrate for regenera-
tion of high-energy phosphate compounds on reperfu-
sion.23 This study demonstrates that preserving the
heart in the beating working state, continuously per-
fused with blood, may prove to be an optimal preser-
vation technique because it fulfills all the aforemen-
tioned criteria.
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Discussion
Dr Vivek Rao (Toronto, Ontario, Canada). I congratulate you
on a very nice study. Our group also has been evaluating contin-
uous perfusion with blood, and I have a couple of questions. 
What about the confounding factors in terms of the tem-
perature differences between your 2 groups? You kept 1
group at 4°C for 12 hours. A lot of evidence has shown that
profound hypothermia in itself is going to be injurious to the
heart. Second, do you consider this to be a truly portable per-
fusion circuit?
Dr Hassanein. We designed the experiments to compare
our preservation technique to the standard 4°C preservation
because 4°C is the clinically applicable technique. Second,
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we believe that the perfusion circuit is portable. At this time
we understand that a significant amount of research and tech-
nology has to be introduced into this technique to make it
more portable and easier to use.
Dr Ahmad Rajaii-Khorasani (Neptune, NJ). I operated on
a patient with a very complex pathologic cardiac condition.
The global ischemic time was 6 hours 45 minutes.
Myocardial protection was with cold blood cardioplegia, and
the patient had a full recovery of cardiac functions soon after
release of the crossclamp and was weaned from bypass with
minimal inotropic support
What is your opinion on the use of the same system that
you described herein, but at hypothermia, with hyperkalemic
arrest. Do you think this may produce superior results? 
Dr Hassanein. Excellent question. We designed a second
experimental protocol addressing hyperkalemic arrest. We
have added a third arm to our study in which we tested the
hypothesis of continuous perfusion of blood cardioplegic
solution at room temperature, 22°C, not normothermia. We
are orthotopically transplanting/reimplanting those hearts
after the period of preservation, compared with the 2 tech-
niques that I mentioned in this study. What we noticed is that,
even though these hearts respond better than the UW group,
significant myocardial edema was noted in this group. That
was the limiting factor of this particular method of preserva-
tion compared with the others. 
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